Manuela Oliveira

Prof. Dr. Manuela Oliveira

IPATIMUP/i3S, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
Manuela OliveiraManuela Oliveira
Manuela Oliveira
WAWilson Antunes
Wilson Antunes
SMSalete Mota
Salete Mota
Áurea Madureira-CarvalhoÁurea Madureira-Carvalho
Áurea Madureira-Carvalho
Ricardo Jorge Dinis-OliveiraRicardo Jorge Dinis-Oliveira
Ricardo Jorge Dinis-Oliveira
DSDiana Dias da Silva
Diana Dias da Silva
Antimicrobial resistance (AMR), frequently considered a major global public health threat, requires a comprehensive understanding of its emergence, mechanisms, advances, and implications. AMR’s epidemiological landscape is characterized by its widespread prevalence and constantly evolving patterns, with multidrug-resistant organisms (MDROs) creating new challenges every day. The most common mechanisms underlying AMR (i.e., genetic mutations, horizontal gene transfer, and selective pressure) contribute to the emergence and dissemination of new resistant strains. Therefore, mitigation strategies (e.g., antibiotic stewardship programs—ASPs—and infection prevention and control strategies—IPCs) emphasize the importance of responsible antimicrobial use and surveillance. A One Health approach (i.e., the interconnectedness of human, animal, and environmental health) highlights the necessity for interdisciplinary collaboration and holistic strategies in combating AMR. Advancements in novel therapeutics (e.g., alternative antimicrobial agents and vaccines) offer promising avenues in addressing AMR challenges. Policy interventions at the international and national levels also promote ASPs aiming to regulate antimicrobial use. Despite all of the observed progress, AMR remains a pressing concern, demanding sustained efforts to address emerging threats and promote antimicrobial sustainability. Future research must prioritize innovative approaches and address the complex socioecological dynamics underlying AMR. This manuscript is a comprehensive resource for researchers, policymakers, and healthcare professionals seeking to navigate the complex AMR landscape and develop effective strategies for its mitigation.

2 December 2008 in International Journal of Biometeorology
Verified
Journal Article
Closed access
PDF file
Manuela OliveiraManuela Oliveira
Manuela Oliveira
Helena RibeiroHelena Ribeiro
Helena Ribeiro
Luís DelgadoLuís Delgado
Luís Delgado
IAI. Abreu
I. Abreu

9 October 2018 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
Manuela OliveiraManuela Oliveira
Manuela Oliveira
Antonio AmorimAntonio Amorim
Antonio Amorim

1 September 2020 in Forensic Science International
Verified
Journal Article
Closed access
Manuela OliveiraManuela Oliveira
Manuela Oliveira
GMGabriella Mason-Buck
Gabriella Mason-Buck
DBDavid Ballard
David Ballard
WBWojciech Branicki
Wojciech Branicki
Antonio AmorimAntonio Amorim
Antonio Amorim

21 September 2017 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
MAMiguel Arenas
Miguel Arenas
Filipe PereiraFilipe Pereira
Filipe Pereira
Manuela OliveiraManuela Oliveira
Manuela Oliveira
NPNadia Pinto
Nadia Pinto
ALAlexandra M. Lopes
Alexandra M. Lopes
Antonio AmorimAntonio Amorim
Antonio Amorim
While traditional forensic genetics has been oriented towards using human DNA in criminal investigation and civil court cases, it currently presents a much wider application range, including not only legal situations sensu stricto but also and, increasingly often, to preemptively avoid judicial processes. Despite some difficulties, current forensic genetics is progressively incorporating the analysis of nonhuman genetic material to a greater extent. The analysis of this material—including other animal species, plants, or microorganisms—is now broadly used, providing ancillary evidence in criminalistics in cases such as animal attacks, trafficking of species, bioterrorism and biocrimes, and identification of fraudulent food composition, among many others. Here, we explore how nonhuman forensic genetics is being revolutionized by the increasing variety of genetic markers, the establishment of faster, less error-burdened and cheaper sequencing technologies, and the emergence and improvement of models, methods, and bioinformatics facilities.

21 March 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Manuela OliveiraManuela Oliveira
Manuela Oliveira
DODiana Oliveira
Diana Oliveira
CLCARMEN LISBOA
CARMEN LISBOA
Jose Laerte BoechatJose Laerte Boechat
Jose Laerte Boechat
Luís DelgadoLuís Delgado
Luís Delgado
Biological particles, along with inorganic gaseous and particulate pollutants, constitute an ever-present component of the atmosphere and surfaces. Among these particles are fungal species colonizing almost all ecosystems, including the human body. Although inoffensive to most people, fungi can be responsible for several health problems, such as allergic fungal diseases and fungal infections. Worldwide fungal disease incidence is increasing, with new emerging fungal diseases appearing yearly. Reasons for this increase are the expansion of life expectancy, the number of immunocompromised patients (immunosuppressive treatments for transplantation, autoimmune diseases, and immunodeficiency diseases), the number of uncontrolled underlying conditions (e.g., diabetes mellitus), and the misusage of medication (e.g., corticosteroids and broad-spectrum antibiotics). Managing fungal diseases is challenging; only four classes of antifungal drugs are available, resistance to these drugs is increasing, and no vaccines have been approved. The present work reviews the implications of fungal particles in human health from allergic diseases (i.e., allergic bronchopulmonary aspergillosis, severe asthma with fungal sensitization, thunderstorm asthma, allergic fungal rhinosinusitis, and occupational lung diseases) to infections (i.e., superficial, subcutaneous, and systemic infections). Topics such as the etiological agent, risk factors, clinical manifestations, diagnosis, and treatment will be revised to improve the knowledge of this growing health concern.